Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribonuclease A family member 9 (RNASE9) is a human secretory protein classified as a non-canonical, catalytically inactive member of the RNase A superfamily. Unlike canonical RNases (RNases 1–8), RNASE9 lacks the catalytic triad and ribonucleolytic activity that characterize typical RNases. It is most closely related by sequence to RNase 7 and RNase 12, sharing ~30% identity. The protein is expressed specifically in the epididymis and is present on the head and neck regions of spermatozoa, suggesting a specialized function in the male reproductive tract, possibly related to host defense and sperm maturation. RNASE9 shows bactericidal effects against E. coli, mediated by its positively charged residues, but does not degrade RNA. No disease associations, therapeutic targeting strategies, biomarkers, safety concerns, or drug interactions are established for RNASE9, and its biological roles outside of the male reproductive tract remain largely unclear.
Not applicable / None described for drug targeting
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribonuclease A family member 9 (RNASE9).